knowledge -WSS

knowledge

author：knowledge 2025-09-29 12:09:09 - browse：76792

Senate Finance Committee Chair Ron Wyden (D-Ore.) Leah Millis/Pool via AP

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies.

The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a drug’s price.

“It’s pretty hard to get 26 votes around here,” Finance Chair Ron Wyden (D-Ore.) said after the vote. “So we’re thrilled.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Supreme Court mifepristone arguments center on docs' right to sue

WSS

Washington mulls new rules to avert another Change Healthcare

Scientists boost immune system in aging mice by making it youthful

Will generative AI in health care meet the fate of IBM's Dr. Watson?

The painfully weak evidence on taking collagen to treat arthritis

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

knowledge

knowledge

Sports medicine is finally prioritizing gender equality

Hospitals use virtual reality to design more inclusive rooms for kids

Affirmative action in medical school literally saved lives

Merck drug for rare lung condition set for approval in U.S.

Heart attack and stroke risk calculators need revising

Astronauts get first look at the spacecraft that will fly them around the moon

Medical leaders decry Supreme Court decision on affirmative action

Travel bans should be based on evidence, not politics or fear

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

explore

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Biden praises World Series champion Astros for impact off the field during White House celebration

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Food as medicine: Medically tailored meals may get standardized

More regulation could be coming for drug ads

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

knowledge

hotspot

leisure time

hotspot